Conversion to Equity. (a) After December 31, 2007, at any time during which Convertible Notes remain outstanding, up to all of the outstanding principal and accrued interest under any particular Convertible Note then outstanding may be converted, at the sole option of the holder thereof and by written notice to the Company, into shares of Common Stock of the Company at a conversion price equal to $2.50 per share.
Appears in 3 contracts
Samples: Convertible Promissory Note Purchase Agreement (Alseres Pharmaceuticals Inc /De), Convertible Promissory Note Purchase Agreement (Alseres Pharmaceuticals Inc /De), Note Purchase Agreement (Boston Life Sciences Inc /De)